Patents by Inventor Michael Batzloff

Michael Batzloff has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Group A streptococcus vaccine
    Patent number: 10513544
    Abstract: The invention relates to methods of eliciting an immune response to group A streptococcal bacteria in a mammal, the method including the step of administering to the mammal an effective amount of a composition comprising an isolated p145 peptide of SEQ ID NO: 56 and/or a p145 peptide variant having an amino acid sequence at least 90% identical to SEQ ID NO: 56, and an isolated SpyCEP peptide of SEQ ID NO: 18 and/or a SpyCEP peptide variant having an amino acid sequence at least 90% identical to SEQ ID NO: 18.
    Type: Grant
    Filed: April 30, 2019
    Date of Patent: December 24, 2019
    Assignee: Griffith University
    Inventors: Manisha Pandey, Michael Batzloff, Michael Good
  • GROUP A STREPTOCOCCUS VACCINE
    Publication number: 20190256562
    Abstract: The invention relates to methods of eliciting an immune response to group A streptococcal bacteria in a mammal, the method including the step of administering to the mammal an effective amount of a composition comprising an isolated p145 peptide of SEQ ID NO: 56 and/or a p145 peptide variant having an amino acid sequence at least 90% identical to SEQ ID NO: 56, and an isolated SpyCEP peptide of SEQ ID NO: 18 and/or a SpyCEP peptide variant having an amino acid sequence at least 90% identical to SEQ ID NO: 18.
    Type: Application
    Filed: April 30, 2019
    Publication date: August 22, 2019
    Applicant: Griffith University
    Inventors: Manisha Pandey, Michael Batzloff, Michael Good
  • Group A vaccine
    Patent number: 10301362
    Abstract: A method and composition for eliciting an immune response to group A streptococcal bacteria in a mammal is provided, which includes administering to the mammal an M protein fragment, variant or derivative thereof and a SpyCEP protein or peptide fragment, or an antibody to the SpyCEP protein or fragment to facilitate restoring or enhancing neutrophil activity. Also provided is an immunodominant peptide fragment of SpyCEP.
    Type: Grant
    Filed: April 15, 2015
    Date of Patent: May 28, 2019
    Assignee: Griffith University
    Inventors: Manisha Pandey, Michael Batzloff, Michael Good
  • GROUP A STREPTOCOCCUS VACCINE
    Publication number: 20170037087
    Abstract: A method and composition for eliciting an immune response to group A streptococcal bacteria in a mammal is provided, which includes administering to the mammal an M protein fragment, variant or derivative thereof and a SpyCEP protein or peptide fragment, or an antibody to the SpyCEP protein or fragment to facilitate restoring or enhancing neutrophil activity. Also provided is an immunodominant peptide fragment of SpyCEP.
    Type: Application
    Filed: April 15, 2015
    Publication date: February 9, 2017
    Inventors: Manisha Pandey, Michael Batzloff, Michael Good
  • Vaccine
    Publication number: 20050002956
    Abstract: Effective stimulation of immune responses is achieved through the use of a group A streptococcal antigen combined with proteosome adjuvant. The compositions are provided in particular for intranasal administration. The vaccine compositions are provided for use in inducing an immune response in an individual for the treatment or prophylaxis of group A streptococcal infection in an individual, preferably via prevention or reduction of colonisation of the throat following intranasal administration.
    Type: Application
    Filed: November 13, 2003
    Publication date: January 6, 2005
    Applicants: ID Biomedical Corporation of Quebec, The Council of the Queensland Institute of Medical Research
    Inventors: George Lowell, Gregory White, Michael Batzloff, David Burt, Tomas Leanderson, Michael Good